Biologic treatments have not been well studied in the treatment of guttate psoriasis.[23] Guttate psoriasis has a better prognosis than plaque psoriasis and typically resolves within 1–3...
Starting this month, Sotyktu (deucravacitinib), an oral treatment for moderate-to-severe plaque psoriasis in adults, receives health insurance benefits in Korea for treating adult patients with chr...
There are many plaque psoriasis treatments that can help manage psoriasis and keep it in check. Learn about your options, risks, and what to expect.
Plaque psoriasis is an inflammatory skin condition that causes raised, itchy patches called plaques. Read to learn more about this condition.
UCB Korea said its dual inhibitor targeting interleukin-17A and 17F, Bimzelx (ingredient: bimekizumab), has been approved by the Ministry of Food and Drug Safety (MFDS) for the treatment of moderate-to-severe plaque psoriasis in adults who require phototherapy or systemic therapy. According to UCB, Bimzelx is the first and only treatment for plaque psoriasis that simultaneously inhibits IL-17A and IL-17F, cytokines that play a central role in the inflammatory process associated with psoriasis. ...
Plaque psoriasis is the most common form of psoriasis, where red patches with a buildup of dead cells show up on your scalp, lower back, elbows & knees.
In This Article ; Symptoms · Causes · Diagnosis · Treatment · Prevention · Complications · Living With Scalp Psoriasis · Frequently Asked Questions
Options for treating plaque psoriasis include topicals, light therapy, and systemic medicines. Learn more about treating symptoms and reducing flares.
It is estimated that nearly 80-90 percent of people living with psoriasis have plaque psoriasis. Have you ever heard of Plaque Psoriasis? Here's all you need to know about its causes, symptoms and...
Food and Drug Administration (FDA) has approved BIMZELX® (bimekizumab-bkzx) for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or...